Liven Pharma Limited (PSX:LIVEN)

Liven Pharma Statistics

Total Valuation

Liven Pharma has a market cap or net worth of PKR 3.93 billion. The enterprise value is 3.96 billion.

Market Cap	3.93B
Enterprise Value	3.96B

Important Dates

The last earnings date was Thursday, February 26, 2026.

Earnings Date	Feb 26, 2026
Ex-Dividend Date	n/a

Share Statistics

Liven Pharma has 113.04 million shares outstanding. The number of shares has increased by 417.79% in one year.

Current Share Class	113.04M
Shares Outstanding	113.04M
Shares Change (YoY)	+417.79%
Shares Change (QoQ)	+1.07%
Owned by Insiders (%)	5.93%
Owned by Institutions (%)	3.51%
Float	105.98M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	46.45
PB Ratio	6.22
P/TBV Ratio	6.29
P/FCF Ratio	n/a
P/OCF Ratio	309.71
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-5.61
EV / Sales	46.78
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-158.44

Financial Position

The company has a current ratio of 1.34, with a Debt / Equity ratio of 0.05.

Current Ratio	1.34
Quick Ratio	0.10
Debt / Equity	0.05
Debt / EBITDA	n/a
Debt / FCF	-1.26
Interest Coverage	-263.22

Financial Efficiency

Return on equity (ROE) is -91.87% and return on invested capital (ROIC) is -82.37%.

Return on Equity (ROE)	-91.87%
Return on Assets (ROA)	-37.42%
Return on Invested Capital (ROIC)	-82.37%
Return on Capital Employed (ROCE)	-75.46%
Weighted Average Cost of Capital (WACC)	1.39%
Revenue Per Employee	2.06M
Profits Per Employee	-17.21M
Employee Count	41
Asset Turnover	0.09
Inventory Turnover	0.65

Taxes

In the past 12 months, Liven Pharma has paid 60.55 million in taxes.

Income Tax	60.55M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -66.05% in the last 52 weeks. The beta is -0.52, so Liven Pharma's price volatility has been lower than the market average.

Beta (5Y)	-0.52
52-Week Price Change	-66.05%
50-Day Moving Average	45.34
200-Day Moving Average	58.18
Relative Strength Index (RSI)	41.11
Average Volume (20 Days)	97,816

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Liven Pharma had revenue of PKR 84.62 million and -705.64 million in losses. Loss per share was -7.49.

Revenue	84.62M
Gross Profit	3.45M
Operating Income	-534.00M
Pretax Income	-645.09M
Net Income	-705.64M
EBITDA	-504.32M
EBIT	-534.00M
Loss Per Share	-7.49

Balance Sheet

The company has 3.29 million in cash and 31.42 million in debt, with a net cash position of -28.14 million or -0.25 per share.

Cash & Cash Equivalents	3.29M
Total Debt	31.42M
Net Cash	-28.14M
Net Cash Per Share	-0.25
Equity (Book Value)	631.91M
Book Value Per Share	6.79
Working Capital	35.01M

Cash Flow

In the last 12 months, operating cash flow was 12.69 million and capital expenditures -37.68 million, giving a free cash flow of -24.98 million.

Operating Cash Flow	12.69M
Capital Expenditures	-37.68M
Free Cash Flow	-24.98M
FCF Per Share	-0.22

Margins

Gross Margin	4.08%
Operating Margin	-631.08%
Pretax Margin	-762.37%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Liven Pharma does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-417.79%
Shareholder Yield	-417.79%
Earnings Yield	-17.95%
FCF Yield	-0.64%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Liven Pharma has an Altman Z-Score of 14.77 and a Piotroski F-Score of 2.

Altman Z-Score	14.77
Piotroski F-Score	2